Myeloproliferative disorder-associated massive splenomegaly.
Mesa
Ruben
R
Department of Hematology, Mayo Clinic, Rochester, Minn., USA.
D002454:Cell Differentiation / Q000187:drug effects*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000150:complications*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D013156:Splenectomy; D013163:Splenomegaly / Q000209:etiology / Q000628:therapy*
D047428:Protein Kinase Inhibitors; D006918:Hydroxyurea